Product Information
SOTALOL 240 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2006 per EA under NDC 00093106301. Its NADAC has been published 237 times since Jan 22, 2014.
FDA first approved this application on May 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093106301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SOTALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075429FDA Approved
5/1/2000
TE Code
AB
On Market Since
5/5/2000
Pharmacological Classes
Price Statistics
The NADAC for SOTALOL 240 MG TABLET has been published 237 times since Jan 22, 2014, and over the history we have for it it has declined 59.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2006 per EA |
|---|---|
| All-time high | $0.4992 (Feb 12, 2014) |
| All-time low | $0.1156 (Aug 20, 2025) |
| 52-week high | $0.2006 |
| 52-week low | $0.1168 |
| Median price | $0.2862 |
| Average price | $0.2464 |
| Largest weekly change | -41.5% (Feb 19, 2014) |
| Weeks tracked | 237 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sotalol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOTALOL 240 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SOTALOL 240 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2006 per EA (NDC 00093106301), effective Sep 30, 2026.
How has the price of SOTALOL 240 MG TABLET changed over time?
Over the history we have for it, the NADAC for SOTALOL 240 MG TABLET has declined 59.8%. It has been tracked across 237 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for SOTALOL 240 MG TABLET?
Since Jan 22, 2014, the NADAC for SOTALOL 240 MG TABLET has ranged from a low of $0.1156 (Aug 20, 2025) to a high of $0.4992 (Feb 12, 2014), with a median of $0.2862 per EA.
Are there cheaper alternatives to SOTALOL 240 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SOTALOL 240 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SOTALOL 240 MG TABLET?
SOTALOL 240 MG TABLET (NDC 00093106301) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.